•
Sep 30, 2023

Stoke Therapeutics Q3 2023 Earnings Report

Total Revenue
$3.31M
Previous year: $2.91M
+13.9%
EPS
-$0.55
Previous year: -$0.66
-16.7%
Gross Profit
$2.11M
Previous year: $1.98M
+6.4%
Cash and Equivalents
$215M
Previous year: $113M
+89.4%
Free Cash Flow
-$17.6M
Previous year: -$24.1M
-26.7%
Total Assets
$240M
Previous year: $278M
-13.6%

Stoke Therapeutics

Stoke Therapeutics